Current or recent past users of hormonal replacement therapy (HRT) have a higher risk of being diagnosed with breast cancer. Before the link between HRT use and breast cancer risk was established, many postmenopausal women took HRT for many years to ease menopausal symptoms (hot flashes, fatigue) and to reduce bone loss. The decision to use hormone therapy after menopause should be made by a woman and her health care provider after weighing all of the potential risks (including heart disease, breast cancer, stroke.
Menopausal Hormone Therapy and Cancer Risk. For decades, women have used hormone therapy to ease symptoms of menopause, such as hot flashes and sweating. This is called menopausal hormone therapy, and you may see it abbreviated as HT or MHT.Last Revised: February 13, 2015. HRT increases your breast cancer risk during the years you take it, but it also helps to relieve many women’s menopausal symptoms. It can also reduce a woman’s risk of developing osteoporosis (weak bones) in the short term and improve muscle strength.
But when HRT is stopped, risk of breast cancer will start to drop back down. It takes about 4 years for the risk to go down to the same level as those who have not used HRT. Beral, V., Bull, D. & Reeves, G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet (London, England) 365, 1543–1551 (2005). However, many women develop breast cancer without any of these risk factors. At Newson Health, the most common reason we hear from women who are scared of taking HRT, is they are worried about the risk of breast cancer. Here are some facts about HRT and breast cancer .
Hormone Replacement Therapy: Exploring the Options for Women 3; Making Decisions: Should I use hormone replacement therapy? (HRT) 4; This position statement has two sections – a synopsis of evidence to date about the use of HRT and breast cancer . Hormone replacement therapy (HRT) with a combination of estrogen and progestogen (although not HRT with estrogen alone) increases the risk for breast cancer to a much greater extent than has.
During 18 years of follow-up, there were more breast cancer deaths among women who took combined hormone therapy, and fewer breast cancer deaths among women who took estrogen alone, compared with women who took placebo. Lung cancer. Women who took combined hormone therapy had the same risk of lung cancer as women who took placebo. However. oestrogen-only HRT is associated with little or no change in the risk of breast cancer ; Because of the risk of breast cancer, it's especially important to attend all your breast cancer screening appointments if you're taking combined HRT. Ovarian cancer. Studies looking at whether HRT can increase your risk of ovarian cancer have so far had.